|
|
|
Volumn , Issue 5-6, 2005, Pages 80-82
|
|
Interleukin-6 as a marker of the activity of a pathological process in patients with psoriasis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
DRUG DERIVATIVE;
INTERLEUKIN 6;
INTERLEUKIN 6 RECEPTOR;
METHYLPREDNISOLONE;
METHYLPREDNISOLONE ACEPONATE;
RECOMBINANT PROTEIN;
ADULT;
ARTICLE;
BLOOD;
BLOOD DONOR;
COHORT ANALYSIS;
COMPARATIVE STUDY;
GENETICS;
HOSPITALIZATION;
HUMAN;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PSORIASIS;
PUVA;
ADULT;
BIOLOGICAL MARKERS;
BLOOD DONORS;
COHORT STUDIES;
COMBINED MODALITY THERAPY;
HUMANS;
INTERLEUKIN-6;
MALE;
METHYLPREDNISOLONE;
MIDDLE AGED;
PSORIASIS;
PUVA THERAPY;
RECEPTORS, INTERLEUKIN-6;
RECOMBINANT PROTEINS;
SEVERITY OF ILLNESS INDEX;
|
|
EID: 33644818235
PISSN: 10195297
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
